订阅小程序
旧版功能

Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-driven Neuroblastoma.

Smita Matkar,Michael P East,Timothy J Stuhlmiller, Gabriela Witek,Alvin Farrel,Steven Pastor,Denis O Okumu, Anne Kennedy, Joshua R Kalna,Esther R Berko,Colleen E Casey,Kateryna Krytska,Khushbu Patel,Jo Lynne Rokita,Mark Gerelus,John M Maris,Gary L Johnson,Yael P Mossé

Molecular cancer therapeutics（2025）

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要